Broad Institute of MIT and Harvard

Broad Institute of MIT and Harvard is a biomedical research institute located in Cambridge, Massachusetts, founded by Eli Broad and Edythe Broad in 2004, in partnership with Massachusetts Institute of Technology and Harvard University. The institute is dedicated to advancing our understanding of the biology and treatment of human disease, and is affiliated with Dana-Farber Cancer Institute, Massachusetts General Hospital, and Boston Children's Hospital. The institute's research is focused on genomics, epigenomics, and chemical biology, and is led by Todd Golub, a renowned expert in cancer genomics and precision medicine. The institute has collaborations with Stanford University, University of California, Berkeley, and University of Oxford.

● History

The Broad Institute of MIT and Harvard was founded in 2004, with a gift of $100 million from Eli Broad and Edythe Broad, and an additional $100 million from Massachusetts Institute of Technology and Harvard University. The institute was established to bring together researchers from MIT and Harvard to work on genomics and genetic engineering projects, and to develop new technologies for DNA sequencing and gene editing. The institute's early research focused on cancer genomics, and was led by Eric Lander, a renowned expert in genomics and computational biology. The institute has also collaborated with Whitehead Institute, MIT Koch Institute for Integrative Cancer Research, and Harvard-MIT Division of Health Sciences and Technology.

● Research

The Broad Institute of MIT and Harvard is a leader in genomics research, and has made significant contributions to our understanding of the human genome and the genetics of disease. The institute's research is focused on cancer genomics, neurological disorders, and infectious disease, and is led by experts such as David Altshuler, Stuart Orkin, and Bruce Walker. The institute has developed new technologies for DNA sequencing, gene editing, and single-cell analysis, and has collaborated with National Institutes of Health, Howard Hughes Medical Institute, and Bill and Melinda Gates Foundation. The institute's research has also been influenced by Cold Spring Harbor Laboratory, Salk Institute for Biological Studies, and University of California, San Francisco.

● Organization

The Broad Institute of MIT and Harvard is organized into several research programs, including the Cancer Program, the Neuroscience Program, and the Infectious Disease Program. The institute is led by Todd Golub, and has a faculty of over 100 researchers, including David Sabatini, Feng Zhang, and Aviv Regev. The institute also has a number of core facilities, including the Genomics Platform, the Epigenomics Platform, and the Chemical Biology Platform, which provide access to cutting-edge technologies and expertise. The institute has partnerships with Pfizer, Novartis, and GlaxoSmithKline, and has collaborated with University of California, Los Angeles, Columbia University, and Johns Hopkins University.

● Facilities

The Broad Institute of MIT and Harvard is located in Cambridge, Massachusetts, and occupies a state-of-the-art research building designed by Skidmore, Owings & Merrill. The institute has over 200,000 square feet of laboratory and office space, and is equipped with cutting-edge technologies, including DNA sequencers, microscopes, and computing clusters. The institute also has a number of core facilities, including the Genomics Platform, the Epigenomics Platform, and the Chemical Biology Platform, which provide access to specialized equipment and expertise. The institute is located near MIT, Harvard University, and Massachusetts General Hospital, and has collaborations with Boston University, Tufts University, and Brigham and Women's Hospital.

● Notable Achievements

The Broad Institute of MIT and Harvard has made a number of significant contributions to biomedical research, including the development of CRISPR-Cas9 gene editing technology, and the creation of the Cancer Genome Atlas. The institute has also made major advances in our understanding of the genetics of disease, including the discovery of genetic variants associated with schizophrenia, bipolar disorder, and autism. The institute's researchers have received numerous awards, including the Breakthrough Prize in Life Sciences, the Lasker Award, and the National Medal of Science, and have been elected to the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences. The institute has also collaborated with European Molecular Biology Laboratory, Wellcome Trust Sanger Institute, and National Cancer Institute.